Evidence map›Paper›PMID 42149187›Full record

ReviewRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer2026

Pre-clinical SPECT and SPECT-CT in Oncology.

Youngho Seo, Elena M Zannoni

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Youngho SeoDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. youngho.seo@ucsf.edu.
Elena M ZannoniWalker Department of Mechanical Engineering, The University of Texas at Austin, Austin, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular imaging enables both spatial and temporal understanding of the complex biological systems underlying carcinogenesis and malignant spread. Single photon emission computed tomography (SPECT) is a versatile nuclear imaging technique with ideal properties to study these processes in vivo in small animal models, as well as to identify potential drug candidates, characterize their anti-tumor action, and potential adverse effects.Small-animal SPECT, SPECT-CT (combined with computed tomography), and SPECT-MR (combined with magnetic resonance imaging) systems continue to evolve, as do the numerous radiopharmaceuticals that can be imaged by SPECT, allowing unprecedented sensitivity and quantitative molecular imaging capabilities. Several of these advances, their specific applications in oncology as well as new areas of exploration are highlighted in this chapter.

Indexed as

NeoplasmsSingle Photon Emission Computed Tomography Computed TomographyTomography, Emission-Computed, Single-PhotonAnimalsHumansRadiopharmaceuticalsRadiopharmaceuticalsAlpha particlesBeta particlesCancer ImagingCollimatorPreclinical SPECTPreclinical SPECT/CTPreclinical SPECT/MRIQuantitative SPECTRadiation detectionRadiation dosimetryTheranostics

Identifiers

PMID42149187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.